Geftib (Gefitinib (250mg))

Geftib Tablet is a medication that may be used to support treatment for certain types of non-small cell lung cancer. It is intended for patients whose condition can benefit from targeted therapy, potentially helping to manage the disease more effectively. This can provide patients with an option for their treatment plan, possibly improving their quality of life.

The active ingredient, Gefitinib, works by targeting specific proteins that help cancer cells grow and divide. By blocking these proteins, Gefitinib may slow down the progression of cancer, making it an important part of a comprehensive treatment strategy.

For best results, it is important to store Geftib Tablets in a cool, dry place, away from direct sunlight and moisture. Consistency in taking the medication as directed is crucial to achieve the desired effect. Patients should also be mindful of any other medications they are taking and discuss potential interactions with their healthcare provider.

Some common mild side effects that may occur include skin rashes, diarrhea, or nausea. These effects tend to be manageable and should be reported to a healthcare professional if they persist or worsen.

This is general information, not a substitute for medical advice. Always consult a doctor/pharmacist and read the package leaflet.